3. TearLab ( TEAR)

Company Profile: Formerly known as OccuLogix, TearLab is an ophthalmic-device company commercializing a proprietary in-vitro diagnostic-tear testing platform, the TearLab test for dry-eye disease.

Altman Z-score: -88.82

Closing Price: $2.62 (Sept. 15)

Financial Metrics: TearLab has a price-to-book ratio of 3.4, which suggests the stock may be overvalued based on book value. TearLab's quick ratio, which measures the ability to meet short-term obligations with its most liquid assets, is 1.5, indicating the ophthalmic device company should be able to meet its current liabilities.

Analyst Consensus: No analyst covers TearLab.

If you liked this article you might like

Analysts' Actions -- eBay, Fitbit, Texas Roadhouse and More

3 Stocks Pushing The Computer Software & Services Industry Lower

3 Stocks Raising The Computer Software & Services Industry Higher

3 Stocks Boosting The Computer Software & Services Industry Higher

3 Stocks Improving Performance Of The Computer Software & Services Industry